Stimulant use in school-age children with ADHD

12 July 2002

One in 8 Australian school-aged children with attention-deficit/hyperactivity disorder (ADHD) has been prescribed stimulant medication, a national survey has found.

The survey — the first to examine the prevalence of psychotropic medication use in Australian children and adolescents — has shown that 12.6 per cent with ADHD are being treated with stimulants, 2.3 per cent with antidepressants and 1.9 per cent with clonidine.

While the researchers were unable to say whether these figures indicated children were being under or overtreated, they did suggest additional information was needed to help clarify when stimulants should be used (Medical Journal of Australia 2002; 177: 21-25).

The study examined 3597 questionnaires, filled in by a parent or main caregiver of children aged 6-17 years. While a total of 1.8 per cent of all children were taking stimulant medication, not all had ADHD. About one-quarter were taking stimulants to treat attention problems or aggressive behaviour.

 


 

Sponsored links

myDr Newsletter

Get myDr delivered to your inbox
Advertisement
See your doctor for diagnosis MIMS Consumer Health Group logo UBM Medica logo Hitwise Top 10 website This website is certified by Health On the Net Foundation. Click to verify. HealthInsite Quality Health Information ABA audited website - click to view latest stats
This web site is intended for Australian residents and is not a sbstitute for independent professional advice. Information and interactions contained in ths Web site are for infomation purposes only and are not intended ot be used to diagnose,treat , cure or prevent any disease.Further , the accuracy, currency and completeness of the information available on this web site cannot be guaranteed. UBM Medica Australia Pty Ltd, its affiliates and their respective servants and agents do not accept any liability for any injury, loss or damage incured by use of or relance on the information made available via or throught myDr whether arising from negligence or otherwise.
See Privacy Policy and Disclaimer.